RNA m 6 A modification regulates cell fate transition between pluripotent stem cells and 2‐cell‐like cells
Cell Proliferation · 2024
DOI: 10.1111/cpr.13696 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Proliferation, 2024. Verfasst von Zhongqu Su und 18 weiteren Autor:innen. Beteiligte Einrichtung: College of Animal Science and Technology, Shandong Key Laboratory of Animal Bioengineering and Disease Prevention, Shandong Agricultural University, …. Hauptthemen laut MEDLINE: Pluripotent Stem Cells, Adenosine, Methyltransferases, RNA-Binding Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Technology of the People's Republic of China, National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
N 6 ‐methyladenosine (m 6 A) exerts essential roles in early embryos, especially in the maternal‐to‐zygotic transition stage. However, the landscape and roles of RNA m 6 A modification during the transition between pluripotent stem cells and 2‐cell‐like (2C‐like) cells remain elusive. Here, we utilised ultralow‐input RNA m 6 A immunoprecipitation to depict the dynamic picture of transcriptome‐wide m 6 A modifications during 2C‐like transitions. We found that RNA m 6 A modification was preferentially enriched in zygotic genome activation (ZGA) transcripts and MERVL with high expression levels in 2C‐like cells. During the exit of the 2C‐like state, m 6 A facilitated the silencing of ZGA genes and MERVL. Notably, inhibition of m 6 A methyltransferase METTL3 and m 6 A reader protein IGF2BP2 is capable of significantly delaying 2C‐like state exit and expanding 2C‐like cells population. Together, our study reveals the critical roles of RNA m 6 A modification in the transition between 2C‐like and pluripotent states, facilitating the study of totipotency and cell fate decision in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Animal Science and Technology, Shandong Key Laboratory of Animal Bioengineering and Disease Prevention, Shandong Agricultural University, Tai'an, Shandong, China.
- Clinical and Translational Research Center of Shanghai First Maternity & Infant Hospital, Frontier Science Center for Stem Cells, School of Life Sciences and Technology, Tongji University, Shanghai, China.
ORCID-Profile: Shaorong Gao
Förderung
- Ministry of Science and Technology of the People's Republic of China
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
- Shanghai Rising-Star Program (A type) of the Science and Technology Commission of Shanghai Municipality
- Science and Technology Innovation Action Plan of the Science and Technology Commission of Shanghai Municipality
- Peak Disciplines (Type IV) of Institutions of Higher Learning in Shanghai
Zitieren
APA
Su, Z., Dong, Y., Sun, J., Wu, Y., Wei, Q., Liang, Y., Lin, Z., Li, Y., Shen, L., Xi, C., Wu, L., Xu, Y., Liu, Y., Yin, J., Wang, H., Shi, K., Le, R., Gao, S., & Xu, X. (2024). RNA m 6 A modification regulates cell fate transition between pluripotent stem cells and 2‐cell‐like cells. Cell Proliferation. https://doi.org/10.1111/cpr.13696
Vancouver
Su Z, Dong Y, Sun J, Wu Y, Wei Q, Liang Y, et al. RNA m 6 A modification regulates cell fate transition between pluripotent stem cells and 2‐cell‐like cells. Cell Proliferation. 2024. doi:10.1111/cpr.13696
BibTeX
@article{Su2024,
author = {Su, Zhongqu and Dong, Yu and Sun, Jiatong and Wu, You and Wei, Qingqing and Liang, Yuwei and Lin, Zhiyi and Li, Yujun and Shen, Lu and Xi, Chenxiang and Wu, Li and Xu, Yiliang and Liu, Yingdong and Yin, Jiqing and Wang, Hong and Shi, Kerong and Le, Rongrong and Gao, Shaorong and Xu, Xiaocui},
title = {RNA m 6 A modification regulates cell fate transition between pluripotent stem cells and 2‐cell‐like cells},
journal = {Cell Proliferation},
year = {2024},
doi = {10.1111/cpr.13696}
}
EUVIMED